Tonix Pharmaceuticals Holding Corp (TNXP)

[powerbattles]

Tonix Pharmaceuticals reveals exciting upcoming milestones in its Phase 3 PTSD trial

NOTE: The Phase 3 RECOVERY trial (P302) for TNX-102 SL (trade name Tonmya) in PTSD will stop enrolling and topline data are expected in the second quarter of 2020. TNX-102 SL for PTSD has U.S. Food and Drug Administration (FDA) Breakthrough Therapy

The agitation in Alzheimer’s disease program is Phase 2 ready with FDA Fast Track designation and the development for AUD is in the pre-Investigational New Drug (IND) application stage.

https://sec.report/Document/0001387131-20-001300/

Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments.
https://www.ncbi.nlm.nih.gov/pubmed/29351298

Tonix Pharmaceuticals Announces Research Collaboration with Southern Research to Develop a Potential Vaccine to Protect Against New Coronavirus Disease 2019 (COVID-19) Based on Horsepox Virus (TNX-1800)

https://ir.tonixpharma.com/press-releases/detail/1191/tonix-pharmaceuticals-announces-research-collaboration-with

Founded in 1941, Southern Research (SR) is an independent, 501(c)(3) nonprofit, scientific research organization with more than 400 scientists and engineers working across four divisions: Drug Discovery, Drug Development, Engineering, and Energy & Environment. SR supports the pharmaceutical, biotechnology, defense, aerospace, environmental, and energy industries as we work on behalf of the National Cancer Institute, National Institutes of Health, the U.S. Department of Defense, the U.S. Department of Energy, NASA, major aerospace firms, utility companies, and other private and government organizations. We pursue entrepreneurial and collaborative initiatives to develop and maintain a pipeline of intellectual property and innovative technologies that positively impact real-world problems. SR is headquartered in Birmingham with additional laboratories and offices in Wilsonville, Alabama; Frederick, Maryland; Cartersville, Georgia; and Houston, Texas./b]
Quote:

We're proud to announce a new collaboration with Tonix Pharmaceuticals to develop a potential vaccine for COVID-19.

https://www.linkedin.com/company/southernresearch

https://southernresearch.org/about/

https://en.wikipedia.org/wiki/Southern_Research